Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers

Clinical Infectious Diseases

Volumn 47, Issue 2, 2008, Pages 176-181

  Datta, Rupak ^a,c   Huang, Susan S ^b,d,e  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; METICILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMORBIDITY; DEATH; DISEASE CARRIER; FEMALE; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BOSTON; CARRIER STATE; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 46349083484     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/589241     Document Type: Article

References (23)

1. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
2. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-44. Erratum in: N Engl J Med 2005; 352:2362.
3. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-8.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
5. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229-35.
6. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13:96-102.
7. Huang SS, Hinrichsen VL, Stulgis L, et al. Methicillin-resistant Staphylococcus aureus infection in the year following detection of carriage [abstract 157]. In: Program and abstracts of the Society of Healthcare Epidemiology of America Annual Meeting (Chicago). Arlington, VA: Society for Healthcare Epidemiology of America, 2006.
8. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281-5.
9. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71.
10. Coello R, Glynn JR, Gaspar C, Picazzo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 1997; 37:39-46.
11. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strain. Am J Med 1996; 100:509-16.
12. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32:1393-8.
13. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphyloccocus aureus. Clin Infect Dis 1994; 19:1123-8.
14. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004:1659-702.
15. Centers for Medicare and Medicaid Web site. Available at: http://www.cms.hhs.gov/QuarterlyProviderUpdates/. Accessed 20 November 2007.
16. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007; 28:1155-61.
17. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-85.
18. Sandri AM, Dalarosa MG, Ruschel de Alcantara L, da Silva Elias L, Zavascki AP. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006; 27:185-7.
19. Lim MSC, Marshall CL, Spelman D. Carriage of multiple subtypes of methicillin-resistant Staphylococcus aureus by intensive care unit patients. Infect Control Hosp Epidemiol 2006; 27:1063-7.
20. Maslow JN, Brecher S, Gunn J, Durbin A, Barlow MA, Arbeit RD. Variation and persistence of methicillin-resistant Staphylococcus aureus strains among individual patients over extended periods of time. Eur J Clin Microbiol Infect Dis 1995; 14:282-90.
21. Fattom A, Fuller S, Propst M, et al. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 2004; 23:656-63.
22. Herwaldt LA, Pottinger JM, Coffman S, Tjaden J. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Veterans Administration Medical Center. Infect Control Hosp Epidemiol 2002; 23:502-5.
23. Huang SS, Diekema D, Warren DK, et al. Strain-relatedness of isolates from patients with serial MRSA infection. Clin Infect Dis 2008 (in press).